AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary
The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal can...
Gespeichert in:
Veröffentlicht in: | Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2021-12, Vol.161 (6), p.2030-2040.e1 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2040.e1 |
---|---|
container_issue | 6 |
container_start_page | 2030 |
container_title | Gastroenterology (New York, N.Y. 1943) |
container_volume | 161 |
creator | Wang, Andrew Y. Hwang, Joo Ha Bhatt, Amit Draganov, Peter V. |
description | The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract. |
doi_str_mv | 10.1053/j.gastro.2021.08.058 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2585906049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508521034867</els_id><sourcerecordid>2585906049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</originalsourceid><addsrcrecordid>eNp9UcFu1DAUtBCILoU_QMhHLgkv3jhNOCCt0mWLVEGl0rPl2C-tV0kcbGel_hWfyNtu4cjpSfbMvHkzjL0vIC9Arj_t83sdU_C5AFHkUOcg6xdsVUhRZwCFeMlWNKpMQi3P2JsY9wDQrOviNTtbl1XdNFW5Yr83uw1vBzc5owd-E7RJziC_m61OyP3Eb5dwQDcMeqLnTZ8w8BudHvzg74-U4ZG3S9DJHZBvJ-uj8bMzxOrGxfhImpcuRiRV0vI93-pAlN2TczcljMlNBPqOfh50dJq7iacHMjC5hJbfJrIRP_PWjyNOSYfHt-xVr4eI757nObv7uv3ZXmXXP3bf2s11ZsqLMmUCKlsI3ZiqMyhAUyCmAtlVAkxTmMZYAdLYpqvtBdK3MTV00EsUwgqpxfqcfTzpzsH_WsinGl00eAwC_RKVkLVsoIKyIWh5gprgYwzYqzm4kbyqAtSxK7VXp67UsSsFtaKuiPbheQOFhfYf6W85BPhyAiDdeXAYVDQOqQfrAiWqrHf_3_AHKZyrcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2585906049</pqid></control><display><type>article</type><title>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Alma/SFX Local Collection</source><creator>Wang, Andrew Y. ; Hwang, Joo Ha ; Bhatt, Amit ; Draganov, Peter V.</creator><creatorcontrib>Wang, Andrew Y. ; Hwang, Joo Ha ; Bhatt, Amit ; Draganov, Peter V.</creatorcontrib><description>The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract.</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2021.08.058</identifier><identifier>PMID: 34689964</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biopsy - standards ; Cancer ; Clinical Decision-Making ; Consensus ; Curative Resection ; Diagnostic Imaging - standards ; Dysplasia ; Early Detection of Cancer - standards ; Endoscopic Mucosal Resection - adverse effects ; Endoscopic Mucosal Resection - standards ; Endoscopy, Gastrointestinal - standards ; ESD ; Gastroenterology - standards ; Gastrointestinal Neoplasms - diagnostic imaging ; Gastrointestinal Neoplasms - pathology ; Gastrointestinal Neoplasms - surgery ; Humans ; Margins of Excision ; Neoplasm Staging ; Predictive Value of Tests ; Surveillance ; Time Factors ; Treatment Outcome ; United States</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2021-12, Vol.161 (6), p.2030-2040.e1</ispartof><rights>2021 AGA Institute</rights><rights>Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</citedby><cites>FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</cites><orcidid>0000-0002-6519-7882</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.gastro.2021.08.058$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34689964$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Andrew Y.</creatorcontrib><creatorcontrib>Hwang, Joo Ha</creatorcontrib><creatorcontrib>Bhatt, Amit</creatorcontrib><creatorcontrib>Draganov, Peter V.</creatorcontrib><title>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract.</description><subject>Biopsy - standards</subject><subject>Cancer</subject><subject>Clinical Decision-Making</subject><subject>Consensus</subject><subject>Curative Resection</subject><subject>Diagnostic Imaging - standards</subject><subject>Dysplasia</subject><subject>Early Detection of Cancer - standards</subject><subject>Endoscopic Mucosal Resection - adverse effects</subject><subject>Endoscopic Mucosal Resection - standards</subject><subject>Endoscopy, Gastrointestinal - standards</subject><subject>ESD</subject><subject>Gastroenterology - standards</subject><subject>Gastrointestinal Neoplasms - diagnostic imaging</subject><subject>Gastrointestinal Neoplasms - pathology</subject><subject>Gastrointestinal Neoplasms - surgery</subject><subject>Humans</subject><subject>Margins of Excision</subject><subject>Neoplasm Staging</subject><subject>Predictive Value of Tests</subject><subject>Surveillance</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>United States</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFu1DAUtBCILoU_QMhHLgkv3jhNOCCt0mWLVEGl0rPl2C-tV0kcbGel_hWfyNtu4cjpSfbMvHkzjL0vIC9Arj_t83sdU_C5AFHkUOcg6xdsVUhRZwCFeMlWNKpMQi3P2JsY9wDQrOviNTtbl1XdNFW5Yr83uw1vBzc5owd-E7RJziC_m61OyP3Eb5dwQDcMeqLnTZ8w8BudHvzg74-U4ZG3S9DJHZBvJ-uj8bMzxOrGxfhImpcuRiRV0vI93-pAlN2TczcljMlNBPqOfh50dJq7iacHMjC5hJbfJrIRP_PWjyNOSYfHt-xVr4eI757nObv7uv3ZXmXXP3bf2s11ZsqLMmUCKlsI3ZiqMyhAUyCmAtlVAkxTmMZYAdLYpqvtBdK3MTV00EsUwgqpxfqcfTzpzsH_WsinGl00eAwC_RKVkLVsoIKyIWh5gprgYwzYqzm4kbyqAtSxK7VXp67UsSsFtaKuiPbheQOFhfYf6W85BPhyAiDdeXAYVDQOqQfrAiWqrHf_3_AHKZyrcw</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Wang, Andrew Y.</creator><creator>Hwang, Joo Ha</creator><creator>Bhatt, Amit</creator><creator>Draganov, Peter V.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6519-7882</orcidid></search><sort><creationdate>202112</creationdate><title>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</title><author>Wang, Andrew Y. ; Hwang, Joo Ha ; Bhatt, Amit ; Draganov, Peter V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biopsy - standards</topic><topic>Cancer</topic><topic>Clinical Decision-Making</topic><topic>Consensus</topic><topic>Curative Resection</topic><topic>Diagnostic Imaging - standards</topic><topic>Dysplasia</topic><topic>Early Detection of Cancer - standards</topic><topic>Endoscopic Mucosal Resection - adverse effects</topic><topic>Endoscopic Mucosal Resection - standards</topic><topic>Endoscopy, Gastrointestinal - standards</topic><topic>ESD</topic><topic>Gastroenterology - standards</topic><topic>Gastrointestinal Neoplasms - diagnostic imaging</topic><topic>Gastrointestinal Neoplasms - pathology</topic><topic>Gastrointestinal Neoplasms - surgery</topic><topic>Humans</topic><topic>Margins of Excision</topic><topic>Neoplasm Staging</topic><topic>Predictive Value of Tests</topic><topic>Surveillance</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Andrew Y.</creatorcontrib><creatorcontrib>Hwang, Joo Ha</creatorcontrib><creatorcontrib>Bhatt, Amit</creatorcontrib><creatorcontrib>Draganov, Peter V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Andrew Y.</au><au>Hwang, Joo Ha</au><au>Bhatt, Amit</au><au>Draganov, Peter V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2021-12</date><risdate>2021</risdate><volume>161</volume><issue>6</issue><spage>2030</spage><epage>2040.e1</epage><pages>2030-2040.e1</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><abstract>The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34689964</pmid><doi>10.1053/j.gastro.2021.08.058</doi><orcidid>https://orcid.org/0000-0002-6519-7882</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0016-5085 |
ispartof | Gastroenterology (New York, N.Y. 1943), 2021-12, Vol.161 (6), p.2030-2040.e1 |
issn | 0016-5085 1528-0012 |
language | eng |
recordid | cdi_proquest_miscellaneous_2585906049 |
source | MEDLINE; Elsevier ScienceDirect Journals; Alma/SFX Local Collection |
subjects | Biopsy - standards Cancer Clinical Decision-Making Consensus Curative Resection Diagnostic Imaging - standards Dysplasia Early Detection of Cancer - standards Endoscopic Mucosal Resection - adverse effects Endoscopic Mucosal Resection - standards Endoscopy, Gastrointestinal - standards ESD Gastroenterology - standards Gastrointestinal Neoplasms - diagnostic imaging Gastrointestinal Neoplasms - pathology Gastrointestinal Neoplasms - surgery Humans Margins of Excision Neoplasm Staging Predictive Value of Tests Surveillance Time Factors Treatment Outcome United States |
title | AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T21%3A44%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AGA%20Clinical%20Practice%20Update%20on%20Surveillance%20After%20Pathologically%20Curative%20Endoscopic%20Submucosal%20Dissection%20of%20Early%20Gastrointestinal%20Neoplasia%20in%20the%20United%20States:%20Commentary&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=Wang,%20Andrew%20Y.&rft.date=2021-12&rft.volume=161&rft.issue=6&rft.spage=2030&rft.epage=2040.e1&rft.pages=2030-2040.e1&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2021.08.058&rft_dat=%3Cproquest_cross%3E2585906049%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2585906049&rft_id=info:pmid/34689964&rft_els_id=S0016508521034867&rfr_iscdi=true |